The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas

Pancreatic ductal adenocarcinoma is a highly malignant tumor with poor prognosis, and the biomarkers for the early diagnosis, targeting therapy, and prognosis are still not clinically available. This study investigated the expression of forkhead box P1 and forkhead box O3a proteins in human pancreat...

Full description

Bibliographic Details
Main Authors: Xin Luo, Zhulin Yang, Xiao Liu, Ziru Liu, Xiongying Miao, Daiqiang Li, Qiong Zou, Yuan Yuan
Format: Article
Language:English
Published: IOS Press 2017-04-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317699129
id doaj-663b1e11dad240c6829c449086e1102c
record_format Article
spelling doaj-663b1e11dad240c6829c449086e1102c2021-05-03T00:43:32ZengIOS PressTumor Biology1423-03802017-04-013910.1177/1010428317699129The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomasXin Luo0Zhulin Yang1Xiao Liu2Ziru Liu3Xiongying Miao4Daiqiang Li5Qiong Zou6Yuan Yuan7Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaResearch Laboratory of Hepatobiliary Diseases, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaResearch Laboratory of Hepatobiliary Diseases, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaResearch Laboratory of Hepatobiliary Diseases, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaResearch Laboratory of Hepatobiliary Diseases, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of Pathology, The Third Xiangya Hospital, Central South University, Changsha, P.R. ChinaDepartment of Pathology, The Third Xiangya Hospital, Central South University, Changsha, P.R. ChinaPancreatic ductal adenocarcinoma is a highly malignant tumor with poor prognosis, and the biomarkers for the early diagnosis, targeting therapy, and prognosis are still not clinically available. This study investigated the expression of forkhead box P1 and forkhead box O3a proteins in human pancreatic ductal adenocarcinoma tumor tissues and pancreatic tissues with and without benign lesions using immunohistochemical staining. Results showed that the positive rates of forkhead box P1 and forkhead box O3a protein expression were significantly lower in pancreatic ductal adenocarcinoma tumors compared to peritumoral tissues, benign pancreatic tissues, and normal pancreatic tissues (p < 0.01). Pancreatic tissues with negative forkhead box P1 and forkhead box O3a protein expression exhibited dysplasia or intraepithelial neoplasia. The positive rates of forkhead box P1 and forkhead box O3a expression were significantly lower in cases with tumor mass >5 cm, lymph node metastasis, invasion to surrounding tissues and organs, and tumor–node–metastasis III + IV stage disease compared to cases with tumor mass ⩽5 cm (p < 0.05), no lymph node metastasis (p < 0.001 and p = 0.001, respectively), no invasion (p = 0.003 and p = 0.004, respectively), and tumor–node–metastasis I or II stage disease (p < 0.05). Kaplan–Meier survival analysis showed that pancreatic ductal adenocarcinoma patients with negative forkhead box P1 and forkhead box O3a expression survived significantly shorter than patients with positive forkhead box P1 and forkhead box O3a expression (p = 0.000). Cox multivariate analysis revealed that negative forkhead box P1 and forkhead box O3a expression was an independent poor prognosis factor in pancreatic ductal adenocarcinoma patients. The area under the curve of a receiver operating characteristic curve was 0.642 for forkhead box P1 (95% confidence interval: 0.553–0.730) and 0.655 for forkhead box O3a (95% confidence interval: 0.6568–0.742). Loss of forkhead box P1 and forkhead box O3a protein expression is associated with carcinogenesis, progression, and poor prognosis in patients with pancreatic ductal adenocarcinomas.https://doi.org/10.1177/1010428317699129
collection DOAJ
language English
format Article
sources DOAJ
author Xin Luo
Zhulin Yang
Xiao Liu
Ziru Liu
Xiongying Miao
Daiqiang Li
Qiong Zou
Yuan Yuan
spellingShingle Xin Luo
Zhulin Yang
Xiao Liu
Ziru Liu
Xiongying Miao
Daiqiang Li
Qiong Zou
Yuan Yuan
The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas
Tumor Biology
author_facet Xin Luo
Zhulin Yang
Xiao Liu
Ziru Liu
Xiongying Miao
Daiqiang Li
Qiong Zou
Yuan Yuan
author_sort Xin Luo
title The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas
title_short The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas
title_full The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas
title_fullStr The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas
title_full_unstemmed The clinicopathological significance of forkhead box P1 and forkhead box O3a in pancreatic ductal adenocarcinomas
title_sort clinicopathological significance of forkhead box p1 and forkhead box o3a in pancreatic ductal adenocarcinomas
publisher IOS Press
series Tumor Biology
issn 1423-0380
publishDate 2017-04-01
description Pancreatic ductal adenocarcinoma is a highly malignant tumor with poor prognosis, and the biomarkers for the early diagnosis, targeting therapy, and prognosis are still not clinically available. This study investigated the expression of forkhead box P1 and forkhead box O3a proteins in human pancreatic ductal adenocarcinoma tumor tissues and pancreatic tissues with and without benign lesions using immunohistochemical staining. Results showed that the positive rates of forkhead box P1 and forkhead box O3a protein expression were significantly lower in pancreatic ductal adenocarcinoma tumors compared to peritumoral tissues, benign pancreatic tissues, and normal pancreatic tissues (p < 0.01). Pancreatic tissues with negative forkhead box P1 and forkhead box O3a protein expression exhibited dysplasia or intraepithelial neoplasia. The positive rates of forkhead box P1 and forkhead box O3a expression were significantly lower in cases with tumor mass >5 cm, lymph node metastasis, invasion to surrounding tissues and organs, and tumor–node–metastasis III + IV stage disease compared to cases with tumor mass ⩽5 cm (p < 0.05), no lymph node metastasis (p < 0.001 and p = 0.001, respectively), no invasion (p = 0.003 and p = 0.004, respectively), and tumor–node–metastasis I or II stage disease (p < 0.05). Kaplan–Meier survival analysis showed that pancreatic ductal adenocarcinoma patients with negative forkhead box P1 and forkhead box O3a expression survived significantly shorter than patients with positive forkhead box P1 and forkhead box O3a expression (p = 0.000). Cox multivariate analysis revealed that negative forkhead box P1 and forkhead box O3a expression was an independent poor prognosis factor in pancreatic ductal adenocarcinoma patients. The area under the curve of a receiver operating characteristic curve was 0.642 for forkhead box P1 (95% confidence interval: 0.553–0.730) and 0.655 for forkhead box O3a (95% confidence interval: 0.6568–0.742). Loss of forkhead box P1 and forkhead box O3a protein expression is associated with carcinogenesis, progression, and poor prognosis in patients with pancreatic ductal adenocarcinomas.
url https://doi.org/10.1177/1010428317699129
work_keys_str_mv AT xinluo theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT zhulinyang theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT xiaoliu theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT ziruliu theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT xiongyingmiao theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT daiqiangli theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT qiongzou theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT yuanyuan theclinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT xinluo clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT zhulinyang clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT xiaoliu clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT ziruliu clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT xiongyingmiao clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT daiqiangli clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT qiongzou clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
AT yuanyuan clinicopathologicalsignificanceofforkheadboxp1andforkheadboxo3ainpancreaticductaladenocarcinomas
_version_ 1721486263490445312